MyFinsight
Home
About
Contact
ormp: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, ORMP has $220,493K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total long-term assets
84,376
62,658
Total assets
220,493
161,684
Total liabilities and equity
220,493
161,684
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Operating lease
right-of-use assets
$817K
Property and equipment,
net
$614K
Amounts funded in
respect of employee...
$40K
Other non-marketable
equity securities
$3,524K
Investment in real estate
$2,122K
Loan to an equity
method investee
$1,044K
Investment in associate at
fair value
$64,803K
Investments at fair value
$11,410K
Long-term deposits
$2K
Prepaid expenses and
other current assets
$1,430K
Investments at fair value
$73,514K
Marketable securities
$4,956K
Short-term deposits
$4,038K
Cash and cash
equivalents
$52,179K
Total long-term
assets
$84,376K
Total current assets
$136,117K
Total assets
$220,493K
Total liabilities and
equity
$220,493K
Total equity
$202,330K
Total long-term
liabilities
$12,044K
Total current
liabilities
$6,119K
Non-controlling interests
-$952K
Total stockholders
equity
$203,282K
Deferred tax liabilities
$7,921K
Operating lease
liabilities
$589K
Employee rights upon
retirement
$38K
Long-term deferred income
$1,496K
Long-term deferred
revenues
$2,000K
Operating lease
liabilities
$271K
Deferred income
$986K
Payable to related
parties
$1K
Accounts payable and
accrued expenses
$4,861K
Accumulated deficit
-$122,575K
Additional paid-in capital
$325,367K
Common stock, 0.012 par
value (60,000,000...
$490K
Subscribe for Financial Insights
ORAMED PHARMACEUTICALS INC. (ORMP)
ORAMED PHARMACEUTICALS INC. (ORMP)